Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. t-control

T-CONTROL

Novel catheter to reduce Urinary Tract Infections (UTIs)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 T-CONTROL project word cloud

Explore the words cloud of the T-CONTROL project. It provides you a very rough idea of what is the project "T-CONTROL" about.

gloves    customers    patients    ratification    foreseeing    acute    life    urinary    revenues    urine    solutions    deaths    feasibility    bn    hospitals    financial    causing    assessing    material    representing    sme    risk    prescribers    emergency    hospitalization    nursing    professionals    retention    guarantee    letters    29    commercializing    made    sharp    uc    investment    14b    catheters    spinal    additional    route    t    injury    decline    stage    interventions    safety    waste    membrane    treatment    difference    catheter    events    plan    rethink    stakeholders    visits    unmet    14    frequent    introduction    days    develops    mainly    million    raised    innovative    linked    alone    ipr    investments    patent    workers    diapers    bags    mentioned    competition    prostate    direct    pave    16    conclude    market    decreasing    continence    cord    hydrophobic    infection    hypertrophy    sheets    care    eur    sl    muscle    quality    medical    business    channels    reduce    approval    previously    custom    special    incontinence    indwelling    substentially    savings    weak    thanks    frequently    health   

Project "T-CONTROL" data sheet

The following table provides information about the project.

Coordinator		 RETHINK MEDICAL SL 

Organization address
address: C/ PRACTICANTE IGNACIO RODRIGUEZ S/N - EDIFICIO PO II DEL CAMPUS UNIVERSITARIO DE TAFIRA
city: LAS PALMAS DE GRAN CANARIA
postcode: 35017
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Spain [ES]
 Project website http://www.rethinkmedical.es
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RETHINK MEDICAL SL ES (LAS PALMAS DE GRAN CANARIA) coordinator 50˙000.00

Map

 Project objective

T-Control is an innovative indwelling urinary catheter. Urinary Catheters (UC) are one of the most frequently used medical devices on the market. They are used during medical interventions and treatment, as well as incontinence or urine retention in case of spinal cord injury, prostate hypertrophy, weak muscle, and many other conditions.

There are several unmet needs related to currently used catheters. They cause a sharp decline of quality of life of the patients, are linked to frequent emergency visits and increase substentially the risk of infection both for patients and health care professionals. There are about 1,3 million cases in EU, causing 1,8 bn EUR direct cost and more than 14,000 deaths.

T-Control is addressing all the previously mentioned problems thanks to its novel design and a special hydrophobic membrane material, with patent approval both in EU and US, developed after 4 years of R&D.

T-Control will reduce additional days of hospitalization (leading to €1.14B savings in EU alone), but also guarantee the safety of health workers and decreasing continence related waste (sheets, gloves, diapers, catheters, bags…) representing around 29% of medical waste in non-acute hospitals.

Rethink Medical SL develops new medical solutions, mainly linked to nursing. It raised the interest of 16 stakeholders on the market (Letters of Support).

The feasibility study (SME Phase 1) shall address a financial plan, foreseeing all the costs and investments associated with commercializing our custom-made UC and the expected revenues. The study will also aim at assessing other important aspects such as IPR management, determine the best investment route for the growth stage, and conclude the best channels to reach customers and how we can best explain our difference from competition (prescribers, events, hospitals…). All these activities will lead to the ratification of a detailed business plan that will pave the way towards an effective market introduction.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "T-CONTROL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "T-CONTROL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More